fashion -WSS

fashion

author：entertainment 2025-09-27 09:55:15 - browse：1262

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： The biotech scorecard for Q1: 17 stock

WSS

White House finalizes ITC's import ban of latest Apple Watches

Videos point to link between seizures and unexplained toddler deaths

Morgan Health, with ambitious aims, wants you to know it’s still here

Rare Northern Lights show in US this week: Where and how to see it

California man arrested in connection with serial murders of Mexican strip club workers

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

entertainment

fashion

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

House panel to mark up pandemic

Malaria cases in Florida and Texas: Here’s what you need to know

Rare Northern Lights show in US this week: Where and how to see it

What does generative AI mean for health care? We asked experts

The FDA must approve intranasal treatments for anaphylaxis

Peter Hotez and the public health issue of online harassment

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

After affirmative action ruling, medical educators look to 'holistic review'

Neutralizing antibodies against HIV shows promise in children

Wikipedia

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

hotspot

explore

hotspot

leisure time